Gynecomastia

(redirected from Gynaecomastia)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

gynecomastia

[‚gīn·ə·kō′mas·tē·ə]
(medicine)
Abnormal enlargement of the mammary glands in the male.

Gynecomastia

 

excessive unilateral or bilateral enlargement of the mammary glands in males, so that they sometimes resemble female glands. Temporary, mild gynecomastia often occurs in adolescent males. Pronounced gynecomastia is one of the symptoms of primary diseases of the endocrine glands, especially the gonads. Patients develop secondary female sex characteristics (feminine pelvis, hips, and voice), lose facial hair, and suffer sexual disturbances. Gynecomastia can also develop in cases of liver diseases (cirrhosis), because of disturbances in estrogen metabolism. Treatment involves elimination of the main disease and sometimes surgery.

References in periodicals archive ?
Further, gynaecomastia causes severe psychological problems affecting social and married life.
Gynaecomastia is enlargement of the ductal and stromal tissue of the male breast and is a common condition amongst peripubertal boys and mature men [1].
Gynaecomastia currently affects 40-60% of men to varying degrees, although this figure is set to rise in line with obesity rates.
The doctors, from Colorado, USA, came to this conclusion after investigating possible causes of gynaecomastia in three boys aged four, seven, and ten years' old who were otherwise healthy and had normal serum concentrations of endogenous steroids.
De novo MECP2 frameshift mutation in a boy with moderate mental retardation, obesity and gynaecomastia.
Considering the several side effects (arrythmias, impotence, gynaecomastia and haematopoeitic changes) of modern medicine, indigenous drugs possessing fewer side effects should be looked for as a better alternative for the treatment of peptic ulcer (Akhtar et al.
Cohn L, Feller A, Draper M, et al: Carpal Tunnel Syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-1 concentrations.
It is called gynaecomastia, begins at 14 and is usually over at 16.
channel inhibitor Eplerenone Aldosterone receptor antagonist; fewer side-effects than spironolactone Spironolactone Aldosterone receptor antagonist; side-effect: gynaecomastia Triamterene Distal tubule [Na.